Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Annals of Internal Medicine. 2014; 161(6):392-9 214. Martensson J, Stromberg A, Dahlstrom U, Karlsson JE, Fridlund B. Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression. European Journal of Heart Failure. 2005; 7(3):393-403 215. Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA et al. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Archives of Internal Medicine. 2001; 161(2):165-71 216. May HT, Horne BD, Levy WC, Kfoury AG, Rasmusson KD, Linker DT et al. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. American Journal of Cardiology. 2007; 217. McDonald K, Ledwidge M, Cahill J, Kelly J, Quigley P, Maurer B et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 and optimal angiotensin-converting enzyme inhibitor dose at discharge. European Journal of 218. McDonald K, Ledwidge M, Cahill J, Quigley P, Maurer B, Travers B et al. Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. Journal of Cardiac Failure. 2002; 8(3):142-8 219. McLellan J, Heneghan CJ, Perera R, Clements AM, Glasziou PP, Kearley KE et al. B-type natriuretic peptide-guided treatment for heart failure. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD008966. DOI: 10.1002/14651858.CD008966.pub2. 220. 